Ignite Creation Date:
2025-12-24 @ 11:44 PM
Ignite Modification Date:
2025-12-25 @ 9:37 PM
Study NCT ID:
NCT00005951
Status:
COMPLETED
Last Update Posted:
2014-08-22
First Post:
2000-07-05
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant Glioma
Sponsor:
Duke University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2000-08
Start Date Type:
None
Primary Completion Date:
2006-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-04
Completion Date Type:
ACTUAL
First Submit Date:
2000-07-05
First Submit QC Date:
None
Study First Post Date:
2003-01-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-08-20
Last Update Post Date:
2014-08-22
Last Update Post Date Type:
ESTIMATED